Squarepoint’s Zimmer Biomet ZBH Stock Holding History

Squarepoint’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,100	Closed	-$1.09M	–	4999
2025 Q3	$1.09M	Buy	11,100 +7,300	+192%	+$723K	﹤0.01%	2621
2025 Q2	$347K	Buy	+3,800	New	+$367K	﹤0.01%	3575
2025 Q1	–	Sell	-7,400	Closed	-$782K	–	5549
2024 Q4	$782K	Buy	+7,400	New	+$794K	﹤0.01%	3305
2023 Q3	–	Sell	-3,700	Closed	-$539K	–	4328
2023 Q2	$539K	Sell	3,700 -8,600	-70%	-$1.17M	﹤0.01%	2576
2023 Q1	$1.59M	Buy	12,300 +3,400	+38%	+$427K	0.01%	1574
2022 Q4	$1.13M	Buy	+8,900	New	+$1.03M	﹤0.01%	1735

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's ZBH Position: Q1 2026 in Review

Squarepoint reduced its Zimmer Biomet (ZBH) stake by 80% in Q1 2026, selling an estimated $15.5M and leaving 42,293 shares worth $3.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Squarepoint first reported a position in ZBH in Q1 2015 and has held it in 38 quarters since. The position peaked at $37.6M in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Squarepoint held 42,293 shares of Zimmer Biomet worth $3.82M as of Q1 2026.
Squarepoint sold 169,310 Zimmer Biomet shares in Q1 2026, an estimated $15.5M.
Zimmer Biomet made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1706 holding.
Squarepoint first reported a position in Zimmer Biomet in Q1 2015 and has held it in 38 quarters since.
Squarepoint's Zimmer Biomet position peaked at $37.6M in Q2 2019.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.